Introduction
COPD is one of the leading causes of mortality and morbidity worldwide. While cigarette smoking is the primary cause and risk factor, many other risk factors contribute to the development or exacerbation of COPD. Outdoor air pollution has been recognized for its impact on human health for centuries, and in the past 50-60 years, particularly in the past 30 years, its adverse impact on COPD sufferers has been intensively studied worldwide. Indoor air pollution using biomass fuel in low-income countries has also been found to contribute to the COPD prevalence, particularly in nonsmoking females. However, over the years, efforts have been made to regulate air pollution levels in many countries around the world, which significantly reduced exposure levels compared to earlier times. It is not very clear how these air quality standards and guidelines, particularly the current ones, impacted the COPD sufferers. This review intends to evaluate the impact of air pollution on COPD sufferers in general and the current air quality standards or guidelines on the COPD sufferers
Results

Introduction to the epidemiology of COPD Definition of COPD
In 1997, a Global Initiative for Chronic Obstructive Lung Disease (GOLD) was launched in collaboration with the US National Heart, Lung, and Blood Institute; National Institutes of Health; and the World Health Organization (WHO). GOLD works with health care professionals and public health officials around the world to raise awareness of COPD and develop and regularly update evidence-based strategy documents to guide COPD diagnosis, treatment, management, and prevention. 1 In its most recent update document (2014), 1 GOLD defines COPD as a preventable and treatable disease characterized by persistent airflow limitation that is usually progressive and associated with enhanced chronic inflammatory response in the airways and the lung to hazardous particles and gases.
Exacerbations and comorbidities contribute to the severity in individual patients.
This definition is similar to that in the updated position paper by the American Thoracic Society and the European Respiratory Society. 2 COPD is not a single disease, but several lung diseases combined. Emphysema and chronic 
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Air quality guidelines impact on COPD sufferers bronchitis are the most important conditions that compose COPD. They frequently coexist, 3 but they are no longer used as separate disease categories and now are included within the COPD diagnosis. 4 Although some patients with asthma also develop poorly reversible airflow limitations and are indistinguishable from patients with COPD, asthma is considered a separate entity 2 not included in the diagnosis and treatment of COPD.
The significant airflow limitation in COPD patients is indicated by the value of forced expiratory volume in 1 second (FEV 1 ) that does not return to normal and frequently worsens over time, but responds largely to bronchodilators. 2 GOLD recommends that any patient with dyspnea, chronic cough or sputum production, and a history of exposure to risk factors such as tobacco smoke or occupational dusts or chemicals should be considered for a diagnosis of COPD, but spirometry is required to make the clinical diagnosis. The presence of a postbronchodilator ratio of FEV 1 and forced vital capacity (FVC) ,0.7 is the confirmation of obstructive airflow limitation. 1 GOLD also classifies the severity of airflow limitation in COPD into four categories in patients with FEV 1 /FVC ,0.7: GOLD 1 (mild) -FEV 1 $80% predicted, GOLD 2 (moderate) -50%# FEV 1 ,80% predicted, GOLD 3 (severe) -30%# FEV 1 ,50% predicted, and GOLD 4 (very severe) -,30% predicted. 1, 5 COPD prevalence and disparity COPD remains a major public health problem worldwide, and is one of the leading causes of morbidity and mortality in both high-and low-income countries. Estimated prevalence rates varied a great deal among different regions and countries possibly due to different methods used in different studies. 5 In the US, based on the National Health Interview Survey conducted by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention and analysis conducted by the American Lung Association, 3 12.7 million US adults have been diagnosed with COPD. The actual number could be as high as 24 million if using the lung function test result, which indicates that there is an underdiagnosis. For chronic bronchitis, .10 million Americans reported a physician diagnosis in 2011. The total prevalence rate was 4.4%, whereas in 1999, the total number was 8.8 million although the prevalence was similar. For emphysema, 4.7 million Americans reported ever being diagnosed and the prevalence rate was 2.0% in 2011. This is a significant increase from 1999 where 2.8 million people were reported representing a prevalence rate of 1.4%. 3 The prevalence rate of COPD was strikingly variable among different races, sexes, and age groups. The rate for chronic bronchitis in 2011 (NCHS) 3 was much higher in nonHispanic whites (4.7%) and blacks (4.9%) than in Hispanics (2.9%) and other non-Hispanics (2.4%). The rate was twice as high in females (5.7%) as in males (3.0%). Prevalence rates were the highest among those 65 years or older (6.4%) and the lowest among those 18-44 years (2.9%) with 70% of cases occurring in those older than 45 years. For emphysema, the prevalence rate in 2011 followed a similar pattern among ethnic groups, which was the highest for non-Hispanic whites (2.4%) followed by blacks (1.8%), other non-Hispanics (1.3%), and Hispanics (0.7%). Females surpassed males in the prevalence rate (2.1% vs 1.9%), although historically, the rate was lower in females. Similarly, prevalence rates for emphysema were the highest among those 65 years or older (5.5%) and the lowest among those 18-44 years (0.3%) with the rate in between (2.7%) for the age group 45-64. 3 Geographically, COPD prevalence rates in the US also varied a great deal among different states as surveyed by the Behavioral Risk Factor Surveillance System in 2011. Kentucky had the highest age-adjusted rate at 9.7%, followed by Alabama at 9.4%, while Minnesota (4.0%) and Washington (4.1%) had the lowest. This geographical difference in COPD prevalence by state parallels the difference in smoking rates where Kentucky was on the top (30.2%) and Washington (17.0%) and Minnesota (15.8%) were on the lowest end. 6 COPD prevalence rate was also the highest for males in Kentucky (8.4%), while the lowest for males in Washington (3.3%) and Washington DC. Among females, Tennessee had the highest age-adjusted rate (11.5%) and Minnesota the lowest (4.3%). Rates tend to be higher in the Midwest and Southeast. 3 Worldwide, 65 million people have moderate-to-severe COPD, 4 and the prevalence is also highly variable. Mannino and Buist 5 summarized the rates from 12 sites in the Burden of Obstructive Lung Disease (BOLD) study 7 and four sites in the Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) study 8 and showed that in both males and females, the highest rate was in South Africa and the lowest in Mexico. The rate for the US was the fifth highest. In the BOLD study for females, the highest rate was in Cape Town, South Africa (16.7%) and the lowest in Guangzhou, People's Republic of China (5.1%). For males, the highest rate again was in Cape Town, South Africa (22.2%) and lowest in Reykjavik, Iceland (8.5%). In the PLATINO study, crude rates of COPD ranged from 7.8% in Mexico City to 19 .7% in Montevideo. 5 International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com
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COPD Mortality and disparity
According to Antó et al, 9 50% of patients are expected to live 10 years post-diagnosis with more than one-third of patients dying due to respiratory insufficiency. COPD is the third leading cause of death in the US after cancer and heart disease. 3 Based on the data from NCHS, the total number has increased from 119,524 in 1999 to 133,965 in 2009 . The number of deaths was consistently higher in females than in males from 2000 to 2009. Approximately 80% of COPD deaths are in non-Hispanic whites; Hispanics had the least number of deaths counting 3,724 in 2009. The overall ageadjusted death rate was 41.2/100,000 in 2009 with the rate the highest (46.0/100,000) for non-Hispanic whites than for other ethnic groups. Overall, non-Hispanic white males had the highest age-adjusted death rates (53/100,000), while other non-Hispanic females had the lowest age-adjusted death rates (11.0/100,000 population). 3 WHO estimated that globally, more than 3 million people died of COPD in 2005, which corresponds to 5% of all deaths. 4 It was known that almost 90% of COPD deaths occurred in low-and middle-income countries. In 2001, WHO estimated that COPD was the fifth leading cause of death in high-income countries and the sixth leading cause of death in low-and middle-income countries. 4 In 2004, WHO updated their findings and concluded that COPD was the fourth leading cause of death for all ages, resulting in 3.0 million deaths worldwide. 10 WHO also estimated that total deaths from COPD are projected to increase by .30% in the next 10 years and will become the third leading cause of death worldwide by 2030. 4 In terms of disability-adjusted life years, COPD is currently seventh and is expected to rise to the fifth leading cause of burden of disease by 2030. 10 
Causes and risk factors
The primary cause of COPD is tobacco smoke, including secondhand smoke or environmental tobacco smoke. 4 Most smokers develop some respiratory impairment due to COPD. 11 WHO estimates that 73% of mortality is related to smoking in high-income countries and 40% to low-to-middleincome countries. 5 In a population cohort study conducted in North Sweden, 12, 13 it was reported that 50% of smokers would develop COPD based on GOLD guidelines.
11
Many other risk factors have been identified in past research 9, 14 that contributed to the development or exacerbation of COPD and have been well summarized in previous reviews. 5, 14, 15 These include genetic and phenotypic traits, occupational exposures to dust and fumes, indoor and outdoor air pollutants, aging, infections, asthma, sex, and socioeconomic status. These risk factors can act singly or synergistically.
It has been suggested that susceptibility to COPD is, at least in part, genetically determined. 16 While the best described genetic factor in COPD is alpha-1 antitrypsin deficiency (PiZZ genotype), present in 1%-3% of COPD patients, 15 several genes have been studied for their associations with COPD. 16, 17 For example, five single nucleotide polymorphisms in ADAM33 gene were associated with COPD and lung function in long-term smokers. 18 The MSR1-coding single nucleotide polymorphism P275A was associated with susceptibility to COPD in smokers and a lower percent predicted FEV 1 , FEV 1 /FVC, and percent predicted forced expiratory flow (25%-75%). 19 Smokers who are carriers of the surfactant protein D AG and AA polymorphic genotypes may be at a higher risk of developing COPD. 16 Retinoic acid receptor-related orphan receptor-α has been implicated in the development of COPD. 20 The hedgehog-interacting protein gene and family with sequence similarity 13, member A (FAM13A1) gene, were suggested to be involved in COPD susceptibility in Chinese Han population. 21, 22 Occupational exposure may make a substantive contribution to the etiology of COPD, particularly, in nonsmokers, females, and young people. 23 Exposed agents include cotton dust, 24 32, 33 or a mixture of them. Most studies reported relative risk (RR) or odds ratio (OR), and a few studies directly reported the percentage of attributable population risk (PAR%). 34 For chronic bronchitis, reported PAR% varied from 11% to 26% with a median at 19%. For lung function impairment, the reported PAR% varied from 12% to 34% with a median at 19%. The reported PAR% also varied for different symptoms. 34 Overall, the PAR% due to occupational exposure was estimated to be 15% in smokers and 20% in nonsmokers. 11, 23 It is suggested that up to 20% of cases of COPD worldwide can be attributed to indoor air pollution from exposure to smoke from cooking and heating with biomass fuels in poorly ventilated dwellings. 11 Age contributing to the risk of COPD was due to the decline in lung function. 5 Infection can predispose individuals for COPD development, and socioeconomic factors represent a combination of risk factors that contribute to the susceptibility for COPD, including poor nutrition and closer proximity to hazardous pollutants. 5 This review focused on air pollution as an etiological factor or risk factor for the development and exacerbation of COPD; for other risk factors, the readers are directed to other review papers in this journal or other journals. 
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Air quality guidelines impact on COPD sufferers Review of the effects of air pollution on COPD sufferers
Outdoor air pollution and COPD mortality Although outdoor air pollution can occur naturally (eg, volcanoes and forest fires), anthropogenic activities are the major cause of environmental air pollution. 35 The concern of outdoor air pollution on human health has been recognized for centuries. 36 The effects of outdoor air pollution have caused a spectrum of responses, such as irritation of the upper respiratory systems, increased prevalence of respiratory infections, and symptoms and clinical signs. Symptoms and signs of respiratory responses include coughing, phlegm production, chest tightness, wheezing, and chronically reduced pulmonary function in FVC and FEV 1 . These symptoms lead to increased incidences in exacerbation of cardiopulmonary diseases, asthma attacks, cancer, and mortality. 2 While air pollution may affect all ages of the population, the elderly, particularly those with preexisting cardiopulmonary diseases such as COPD, are the most susceptible group.
Air pollution causing COPD-related mortality was well presented when air pollution catastrophes significantly increased death rates. For example, in the UK historically, the burning of coal in homes for domestic heat often created very high levels of air pollution and caused death rates to dramatically rise. One of the most well-known pollution events was the 1952 London Smog incident that resulted in 4,000 extra deaths, with 80%-90% of the deaths due to cardiorespiratory causes. The greatest relative increase was in deaths due to bronchitis, which rose ninefold. 37, 38 The pollutant involved in the London Smog incident was black smoke, defined as visual blackness of particles collected on a white filter expressed as equivalent mass concentration of standard coal smoke 39 and sulfur dioxide (SO 2 ). A later estimation indicated that 12,000 extra deaths occurred from December 1952 through February 1953 because of acute and persisting effects of the 1952 London Smog incident. 40 A time series analysis conducted for the data from 1958 to 1972 indicated that particulates were strongly associated with mortality rates in London even at much lower levels, and the relation was likely causal. 41 A more recent study on the health effects of an air pollution episode in London, December 1991, in which concentrations of nitrogen dioxide (NO 2 ) rose to record levels with moderate increases in black smoke showed a 23% increase in COPD mortality. 42 Earlier, before the London Smog incident in 1930, the Meuse Valley, Belgium, experienced a period of intense fog in a heavy industrial area resulting in the death of 60 people. 43 In
October 1948, a lethal haze enveloped the town of Donora, PA, US. Over 5 days, approximately half of the town's 14,000 residents experienced severe respiratory and cardiovascular problems. The death toll rose to ~40 people. 44 The 1952 London Smog and other air pollution events symbolized the beginning of the modern air pollution epidemiologic studies. They also prompted governments to pass legislation to reduce air pollution levels. As legislation over the years has led to a decrease in traditional air pollutants particulate matter (PM) and SO 2 from stationary sources, today's major air pollutants come from motor vehicle traffic, and the main perpetrators include PM, ozone (O 3 ), and NO 2 .
37
A commentary and review by Dockery 39 well described how studies on the health effects of particulate air pollution evolved and helped improve the air quality standards and regulations in the US. The year 1970 was a milestone year when Congress passed the Clean Air Act Amendments that required the Environmental Protection Agency (EPA) to set up the first National Ambient Air Quality Standards (NAAQS) that included six types of air pollutants: carbon monoxide (CO), lead, NO 2 , O 3 , PM, and SO 2. NAAQS was promulgated in 1971. The particles used then were total suspended particles (TSP) with aerodynamic diameter between 20 µm and 50 µm, which was set up as maximum allowable ambient concentration. 39 The Clean Air Act also encouraged scientists to identify pollutants that may reasonably be anticipated to endanger public health and welfare. 39 One of the earliest and largest air pollution studies in the US was the Harvard prospective cohort study of the respiratory health effects of respirable particles and SO 2 on a sample of adults and children in six US cities, that began in 1974. The particles measured in this study included two classes: fine particles (aerodynamic diameter ,2.5 µm [PM 2.5 10 ] starting in 1984). 45 Over the 16-year follow-up, the study found a positive association of air pollution with both mortalities from lung cancer and cardiopulmonary causes, after adjusting for smoking and other risk factors. The adjusted mortality rate ratio for the most polluted of the cities as compared with the least polluted was 1.26 (95% confidence interval [CI], 1.08-1.47) or 26% of excess mortality. Mortality was most strongly associated with air pollution with fine particulates, including sulfates. 45 This study and others [46] [47] [48] provided scientific evidence that supported the US EPA's replacement of the TSP standard with a standard for PM 10 in 1987. 49 In 1997, EPA further amended the particle standard and added PM 2.5 to recognize the potentially different health effects. Sidney, Australia New onset of chronic phlegm 
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Air quality guidelines impact on COPD sufferers This switch to a more health-related exposure metric stimulated studies of the associations between ambient air PM and mortality, morbidity, and cardiopulmonary function indices. Over the past 30 years, a great number of studies, particularly time series studies, were conducted around the world to evaluate daily air pollution concentrations (shortterm exposure) and the daily increased mortality with or without a few days of lag of exposure. 36 PM was the focus of these studies, but gaseous criteria air pollutants were often included for their independent effects or interaction with and modification of PM effect. PM size evaluation evolved from TSP to PM 10 and then to PM 2.5 . Earlier studies mostly focused on a single city, and many evaluated total mortality or mortality due to cardiorespiratory diseases or respiratory diseases, [50] [51] [52] [53] [54] [55] [56] and the effect size was often provided with higher units of exposure (100 µg/m 3 or quartile increase of the studies). 55, 57, 58 More recent studies tend to focus on COPD as a separate category [59] [60] [61] [62] [63] [64] [65] where the effect size was based on 10 µg/m 3 . [59] [60] [61] [62] 64, 65 These studies in a single city or multi cities around the world described earlier have repeatedly shown the increase in mortalities for all causes, for cardiopulmonary diseases, and for COPD associated with both short-term and long-term exposures to air pollution, although the exact percentage of increase (effect size) was variable among studies, time periods, pollutants, and cities. It was suggested that particles are the major culprit among the air pollutants and the role of other pollutants, if any, was additive and not multiplicative. Table 1 summarizes main studies [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] published on outdoor air pollution and COPD mortality thus far. To be comparable, recent studies [59] [60] [61] [62] 64, 65 that used the same exposure unit (10 µg/m 3 ) for particles are summarized in Figure 2 . The mean percent of change in mortality per 10 µg/m 3 increase in particle exposure ranged from -1 for PM 2.5-10 with a 0-1-day lag in a study conducted by Samoli et al 65 in ten European Mediterranean metropolitan areas to 6.1 for PM 10 with a 5-day mean exposure in a study conducted by Tellez-Rojo et al 59 in Mexico City, Mexico. The effect sizes for other studies [60] [61] [62] 64 are in between with an average effect size at 1.12. The effect size ranged from 1.0 to 3.5 for SO 2 Notes: Case-control and cross-sectional prevalence studies used chi-square test, Mantel-Haenszel method, and logistic regression or multivariate regression for data analysis on OR and trends, adjusting for variables such as age, sex, marital status, education, body mass index, alcohol use, active and passive smoking, occupational exposures, atopy and family history of COPD, place of birth, and residence and family income. Pollutant names are the same as in previous tables. Abbreviations: CI, confidence interval; BMRC, British Medical Research Council; LPG, liquefied petroleum gas; ATS, American Thoracic Society; OR, odds ratio; CB, chronic bronchitis; PM 10 , particulate matter with aerodynamic diameter #10 µm; TSP, total suspended particles; AP, attributable proportion
where P is the prevalence of the exposure among the cases; CO, monoxide; FvC, forced vital capacity, the amount of air a person can expire after a maximum inspiration; RR, relative risk; SO 
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Liu et al Figure 1 Article identification, screening, evaluation on eligibility and inclusion.
obstruction, and deranged gas exchange are also important contributors. Patients who die during air pollution episodes include not only those with a very short life expectancy (this mechanism has been called "harvesting") but also patients and subjects with a much longer life expectancy. 68 Outdoor air pollution and COPD morbidity
While mortality due to air pollution represents the extreme outcome for COPD sufferers, there is a continuum of health effects that also include the impact on the morbidity such as increased acute respiratory symptoms, reduced lung functions, exacerbation of COPD conditions that may be severe enough to require physician visits, use of ambulance, hospital respiratory admissions, and emergency room visits. 69 COPD sufferers are particularly vulnerable to additional stress on the respiratory system caused by the toxic effects of inhaled pollutants. The London Smog incident of December 5-9, 1952, caused total hospital admissions to rise by 50% and respiratory admissions to rise by 160%. 37 The later Smog event in 1991 caused a 43% increase in hospital admission. 42 Similarly in the past 30 years, particularly since the early 1990s, many epidemiologic studies have been conducted around the world to evaluate short-term exposure to air pollution and the morbidity of respiratory diseases overall or COPD specifically. These studies that assessed the mortality often also evaluated the morbidity. Table 2 summarizes the  27 studies 70-96 conducted in high-income countries that specifically evaluated the increased risk of hospital admission or emergency room visits due to COPD cause. Exposures assessed included both PM and gaseous pollutants, and the exposure unit used to assess the effect size of particles varied among studies and often was 50 µg/m 3 and 100 µg/m 3 or in the interquartile range (IQR) of the measured data in earlier studies. Recent studies tended to use 10 µg/m 3 . Figure 3A summarizes the effect sizes from different authors with different particle sizes and lag times per increase in 10 µg/m 3 . 74, 85, [88] [89] [90] [91] [92] 94, 95 The percent increases ranged from 0.02 for PM 2.5 
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Air quality guidelines impact on COPD sufferers (percent increases) for gaseous pollutants were also variable among the studies. For SO 2 , the percent change ranged from 2 in a study by Sunyer et al 70 in Barcelona, Spain, to as high as 39 in a study by Pönkä and Virtanen 72 in Helsinki, Finland, although these studies were not directly comparable as they used different exposure units. For NO 2 , recent comparable studies 90, 92, 94 showed an increase in risk from 1.2% 94 Figure 3B ). This is similar in magnitude to that in high-income countries. For SO 2 The above studies provided strong evidence that both particles and gaseous air pollutants can increase the hospital Figure 2 Outdoor air pollution and COPD-related mortality in both high-and low-to middle-income countries: increased risk for COPD per increase in particle exposure (10 µg/m 3 ). Abbreviations: PM 10 , particulate matter with aerodynamic diameter #10 µm; PM 2.5 , particulate matter with aerodynamic diameter #2.5 µm; PM 2.5-10 , particulate matter with aerodynamic diameter between 2.5 µm and 10 µm; CI, confidence interval.
International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com
Dovepress
862
Liu et al admissions or visits to emergency departments due to COPD exacerbation in both high-income and low-to middle-income countries, although the effect size is variable among study locations and different pollutants. The effect size also seems to be higher in gaseous pollutants, particularly in low-income countries.
Outdoor air pollution on respiratory symptoms and lung function Several studies have also been conducted to evaluate the prevalence and incidence of COPD or chronic bronchitis and/or respiratory symptoms and lung functions (FVC, FEV 1 , or both) due to short-term or long-term exposure to outdoor air pollution. Table 4 summarizes 15 of such studies. [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] Exposures often were measured qualitatively as how close the home was to a major road with high traffic, although air pollutants were also measured in some of the studies. The prevalence of COPD ranged from 0.26% in Pietracupa, Italy, 112 to 4.5% in Rhine-Ruhr basin, Germany, 113 and the prevalence of chronic bronchitis was 4%. 115 Increased risks with different effect sizes were observed for symptoms such as cough and phlegm, 114, 117, 118 reduced lung functions, 110, 112, 113, 118, 121 and prevalence or incidence of COPD or chronic bronchitis 113, 116, [118] [119] [120] 122 in different populations and various regions of the world. The amount of decreased FEV 1 was reported to be from 2.1 mL/year per increase in PM 2.5 (2 µg/m 3 ) or 5.0 mL/year if living in ,100 m distance to a major road in Framingham, US, 121 to 23.6 mL/year in males in a Los Angeles study. 110 These effect sizes delineated the risks of chronic exposure to outdoor air pollution in the general population.
Outdoor air pollution on COPD patients
Another type of time series study is the panel study with COPD patients to evaluate the daily variations of air pollution directly on their exacerbation (increased symptoms and reduced lung 
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Air quality guidelines impact on COPD sufferers functions). However, relatively fewer of such studies have been conducted, and the results on the effects are inconsistent. Table 5 presents the details for ten panel studies. [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] One of the earliest panel studies was conducted by Lawther et al. 124 They used diary cards to assess the symptoms of bronchitis related to the change in air pollution levels in patients and found a 28% overall increase in worsened symptom rates. The panel studies in the past 25 years showed a variety of exacerbations on the COPD patients ranging from increased respiratory symptoms, blood pressure, and inhaler and nebulizer use, reduced lung function, and limits in physical activities to death, although the effect sizes were variable among different studies in different regions. Most of these studies used a small number of COPD patients. The largest study identified was conducted by Sunyer and Basagaña 128 in Barcelona, Spain, with 2,305 COPD patients .35 years of age. An IQR increase of 27 µg/m 3 in PM 10 resulted in an all-cause mortality increase of 11%.
The above review indicated that outdoor air pollution, especially particulate air pollution, has been consistently linked to various health effects on COPD sufferers ranging from increased respiratory symptoms, decreased pulmonary function, exacerbation leading to increased hospitalization admissions and emergency room visits, and mortality due to cardiopulmonary disease. These health effects are observed at levels common to many US cities, including levels below the maximum set by the US NAAQS at the time of the studies. 134 Indoor air pollution and impact on COPD sufferers 
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Liu et al to five times higher than typical outdoor concentrations. 135 According to WHO, almost three million people or 50% of the households worldwide use biomass as the main source of energy for cooking, heating, and other household needs, such as wood, crop residues, and animal dungs in addition to coal. Biofuels have higher emission factors for PM and other pollutants, especially during incomplete combustion at lower temperatures. 136 The burning of biofuels generates indoor airborne particles at levels much higher than those of cleaner fuels 137 or outdoor levels, 138 and well above levels in most polluted cities. 139 Such particles also have small aerodynamic diameters (eg, ranging from 0.05 µm to 1 µm for wood smoke) 140 and can penetrate deep into the alveolar region to induce adverse pulmonary effects.
Indoor air pollution studies dated back to as early as the 1960s when wood smoke exposure and chronic lung diseases were investigated in Papua and New Guinea. [140] [141] [142] Since the early 1980s, there have been quite a few studies conducted to evaluate indoor exposure to biomass air pollution and the odds of increased chronic bronchitis or/and COPD, particularly in low-income countries where only lower grade energy resources are available and affordable. Table 6 summarizes 21 studies 143-163 conducted in low-income countries identified through this search in which exposed populations were largely nonsmoking females, but exposed to smoke from cooking and heating using biomass fuels since early childhood with their mothers or later as housewives. Most studies 1) were population-based cross-sectional surveys [143] [144] [145] [149] [150] [151] [152] [153] [154] [157] [158] [159] [160] [161] [162] [163] or case-control design, [146] [147] [148] 156 and only one study was identified as a (retrospective) cohort study; 155 2) used standard questionnaires such as questionnaires from American Thoracic Society and the British Medical Research Council with adaptations appropriate to local culture, along with or without the lung function testing to identify cases, but few studies used the GOLD standard for diagnosis; 3) assessed exposure using fuel type, stove type, poor ventilation, or time spent cooking and rarely measured actual exposure levels to particles and gasses; and 4) measured the prevalence of chronic bronchitis and/or respiratory symptoms with COPD in most earlier studies or COPD only in recent studies, analyzed OR for indoor biofuel use, or conducted a crude dose-response relationship analysis using cooking time per year as a cumulative exposure measurement. Unit air concentration-based effect sizes were not available. However, a consistent relationship between indoor exposure to biomass cooking and excess risk was found from different countries. The prevalence (%) of chronic bronchitis in study villages with indoor biomass cooking varied from 1.79 in India 163 to 28.5 in Turkey, 153 which is overall higher than in high-income countries. The prevalence for urban control area homes, outdoor cooking practice, and cleaner fuels such as gas and electricity tended to be much lower. 148 for chronic bronchitis and COPD combined, and 2.3 (95% CI 1.2-4.4) to 2.9 (95% CI 1.7-5.1) for various respiratory symptoms. 162 It was reported that if cumulative exposure is .60 hour-years, the OR for chronic bronchitis is significantly increased. 163 Reported attributable portion of risk was 23.1%. 153 These results indicated that overall, evidence supporting an association between biomass smoke exposure and COPD in adult females in rural areas is fairly robust. 164 
Impact of current air quality guidelines on COPD sufferers
Epidemiologic studies worldwide have provided strong evidence to link air pollution, especially particulate air pollution to the mortality, morbidity, and socioeconomic burden of cardiorespiratory disease in general and COPD in particular. This has prompted the legislation around the world to continuously modify the air quality standards or guidelines to reduce the disease burden over time such as in the US. 49, 165 WHO provides the basis for global standards in environmental quality and effective investments for public health. 166 WHO published its air quality guidelines in 1987 and revised them in 1997. Based on the research developments thereafter, they updated the guidelines for PM, O 3 , NO 2 , and SO 2 in 2005. 166 The values in the WHO guidelines are much lower than in the US NAAQS. 167, 168 We focused this part of the review on studies conducted in the last 10 years to specifically evaluate if the current air quality guidelines are protective of COPD sufferers.
A prospective cohort study 119 in Copenhagen, Denmark, with 57,053 participants assessed the effect of exposure to traffic air pollution (NO 2 and nitrogen oxides [NO x ]) over 35 years on the incidence of COPD. The modeled 35-year mean of outdoor NO 2 level was 17.0 µg/m 3 or 9 ppb for the total population and 18.1 µg/m 3 or 9.6 ppb for COPD patients. These levels were well below the current NAAQS NO 2 standard of 53 ppb for annual mean. The study found that COPD incidence was associated with the 35-year mean NO 2 level (hazard ratio 1.08; 95% CI 1.02-1.14, per IQR 3 ) was five times more in COPD patients (3.5%, 95% CI -0.1%-7.2%) than in other subjects (0.7%, 95% CI -0.8%-2.2%). The effects on respiratory mortality among COPD subjects were particularly elevated for PM 2.5 (IQR 11 µg/m 3 ; 11.6%, 95% CI 2.0%-22.2%) and NO 2 (IQR 24 µg/m 3 ; 19.6%, 95% CI 3.5%-38.2%). 169 In Vancouver, Canada, a population-based study 170 with 467,994 residents aged 45-85 years without COPD had a 5-year exposure period and a 4-year follow-up period. The 5-year average concentrations were 4.10 µg/m 3 for PM 2.5 and 32.2 µg/m 3 (or 17 ppb) for NO 2 . In unadjusted single-pollutant models, PM 2.5 , NO 2 , and NO were associated with COPD hospitalization and mortality, although after adjustment for covariates, these air pollutants were not significantly associated with COPD hospitalization and mortality. 170 As described earlier, Schikowski et al 113 showed that chronic exposure to PM 10 , NO 2 , and living near a major road might increase the risk of developing COPD. The annual mean level was 39 µg/m 3 (or 20.7 ppb) for NO 2 and 44 µg/m 3 for PM 10 (Table 4) . In a New Zealand study with COPD patients (Table 5) , 125 SO 2 and NO 2 and most PM 10 concentrations were well below their air quality guidelines, but increased risk of chest symptoms for PM 10 in the night time and increased use of an inhaler and nebulizer for NO 2 were observed. Sulzbach 171 commented that epidemiological studies have shown that sensitive populations are prone to exacerbated health effects even when the air quality measurements are within the EPA standards. Specifically, Sulzbach investigated Minnesota to determine the constituents of the air pollution and measure the level of air pollution in the Twin Cities. The result of the study showed that Minnesota was one of eleven states that met federal air quality health standards at the time. However, there were still a significant number of days when the air quality could trigger health problems in sensitive populations. 171 Bell et al 172 estimated a national average relative rate of mortality associated with short-term exposure to ambient O 3 for 95 large US urban communities from 1987 to 2000. They found that a 10 ppb increase in the previous week's O 3 was associated with a 0.52% increase in daily mortality (95% posterior interval [PI], 0.27%-0.77%) and a 0.64% increase in cardiovascular and respiratory mortalities (95% PI, 0.31%-0.98%). They indicated that even though the US EPA's 8-hour regulation was met every day in each community, there was still a 0.30% increase in mortality per 10 ppb increase in the average of the same and previous days' O 3 levels (95% PI, 0.15%-0.45%). Therefore, they suggested that interventions to further reduce O 3 pollution levels should be implemented so as to benefit public health, even in regions that meet current regulatory standards and guidelines. 173 The WHO advised that due to the lack of thresholds of air pollutants at which adverse health effects occur, the guidelines proposed cannot fully protect human health. 166 It should be noted that there were also some studies that do not support the associations between outdoor and indoor air pollution and the burden on COPD sufferers. For example, Schikowski et al 174 
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Liu et al in Greece with 3,046 subjects found no association between air pollution and the development of COPD. 176 Although further research is needed to better assess the relationship, the majority of the literature has indicated that the impact on COPD suffers, including morbidity and mortality, due to air pollution is still detectable under the current air quality guidelines.
Discussion
Implications for future policy and decision-making
To reduce the impact of outdoor/indoor air pollution on COPD sufferers, a range of strategies and approaches need to be sought, which are summarized in the following categories based on this literature review.
Amendment to further lower current standards and guidelines
To evaluate whether improved air quality standards reduce the adverse health effects, the Harvard six cities study extended mortality follow-up for 8 years in a period of reduced air pollution concentrations. 177 They focused on the PM 2.5 concentrations, which were measured between 1979 and 1988 and estimated for later years from publicly available data. It was found that an increase in overall mortality was associated with each 10 µg/m 3 increase in PM 2.5 modeled either as the overall mean (rate ratio 1.16; 95% CI 1.07-1.26) or as exposure in the year of death (rate ratio 1.14; 95% CI 1.06-1.22). Improved overall mortality was associated with a decreased mean PM 2.5 (10 µg/m 3 ) between periods (rate ratio 0.73; 95% CI 0.57-0.95). 177 This suggests that the mortality effects of long-term air pollution may be at least partially reversible. 39 Pope et al found that a decrease of 10 µg/m 3 in the concentration of fine PM was associated with an estimated increase in mean (± standard error) life expectancy of 0.61±0.20 years (P=0.004). Reductions in air pollution accounted for as much as 15% of the overall increase in life expectancy in the study areas. 178 This indicates that it is beneficial to further tighten the current air quality guidelines around the world to reduce exposure levels and the effects on the general population and COPD sufferers.
Interventions to reduce sources of outdoor air pollution
The study conducted by Dockery et al 179 in the Republic of Ireland well illustrated that reducing the air pollution from the source might be the most effective way to improve the air quality. In Ireland, domestic coal burning was a major source of repeated severe pollution episodes. The government introduced sequential bans in 1990, 1995, and 1998 on the marketing, sale, and distribution of coal in different cities. The authors compiled records of daily black smoke, total gaseous acidity (SO 2 ), and counts of cause-specific deaths from 1981 to 2004 for several cities and counties. They also compiled daily counts of hospital admissions for cardiovascular, respiratory, and digestive diagnoses. They compared the results with counties not affected by the bans. The mean black smoke concentrations fell in all affected population centers post-ban compared with the preban period, with decreases ranging from 4 µg/m 3 to 35 µg/m 3 (corresponding to reductions of 45% to 70%, respectively). Respiratory mortality was reduced in association with the bans in 1990, 1995, and 1998 (17%, 9%, and 3%, respectively). A 4% decrease in hospital admissions for cardiovascular disease associated with the 1995 ban and a 3% decrease with the 1998 ban were found, and admissions for pneumonia, COPD, and asthma were reduced. 179 Boogaard et al 180 found that implementing local traffic policies including low emission zones directed at heavy duty vehicles (trucks) in five Dutch cities reduced all pollutant levels, especially PM 2.5 levels (20%-30%) and NO 2 and NO x levels (25%-41%) in various areas. A recent review indicated that overall air pollution interventions have succeeded at improving air quality and also have been associated with health benefits, mainly reduced cardiovascular and/ or respiratory mortality and/or morbidity. 181 These studies suggest that exposure control at the source can more efficiently reduce the air pollution level and therefore the human exposure and adverse outcomes.
Intervention to reduce indoor biomass air pollution in low-income countries
Since most countries probably do not have indoor air pollution standards and indoor air environments are generally not regulated, other measures to reduce indoor exposures to air pollutants from biomass or other solid fuels need to be developed, which could include a range of methods targeting the emission source (improved cook stoves or cleaner fuels), the indoor environment (improved ventilation and better design to separate the sources from main activity rooms), and the residents' behaviors (to avoid direct exposure to the sources and for females not to carry young children on their back during cooking as this is a tradition in some rural areas in low-income countries 183 The intervention measures included improving kitchen ventilation (providing instruction or installing exhaust fans) and promoting the use of clean fuels (ie, biogas) instead of biomass for cooking (providing instruction and installing household biogas digesters). The study found that the combined intervention measures reduced the decline in FEV 1 , with a slowing rate of 16 mL/year (95% CI 9-23 mL/ year). The longer the duration of the intervention measures used, the slower the decline of FEV 1 . The reduction in the overall risk of COPD was an OR of 0.28 (95% CI 0.11-0.73) for both intervention measures.
Intervention measures such as improved stoves, cleaner fuels, and other feasible and economical methods need to be tailored to the situation in each community based on affordability, effectiveness, and local culture so as to reduce the high exposure to biomass pollution and large COPD burden in nonsmoking females in low-income countries.
Integrated intervention and management program for COPD sufferers
A total of 1,062 subjects with or without COPD in a study in Guangdong, People's Republic of China, by Zhou et al 184 randomly evaluated the effectiveness of integrated interventions, which included systematic health education, intensive and individualized intervention, treatment, and rehabilitation. The annual rate of decline in FEV 1 was significantly lower in the intervention community than in the control community, with an adjusted difference of 19 mL/ year (95% CI 3-36) and 0.9% (0.1%-1.8%) of predicted values (all P,0.05), as well as a lower annual rate of decline in FEV 1 /FVC ratio at 0.6% (0.1%-1.2%). Shofer et al 185 recommended that patients at increased risk for adverse effects of inhaled air pollutants, such as those who have been diagnosed with chronic lung disease and cardiovascular disease, including asthma, COPD, coronary artery disease, congestive heart failure, and peripheral vascular disease, should be educated regarding what symptoms may be related to poor air quality and how they can monitor the Air Quality Index to modify their activity to prevent symptoms and other adverse events. Heavy outdoor exertion should be avoided on days expected to have poor air quality or performed earlier in the day on days when outdoor activity cannot be avoided.
Conclusion and future directions
While air quality standards and guidelines have reduced human exposure overall and exposure of COPD sufferers in particular to PM and gaseous air pollutants around the world, health effects measured as mortality and morbidity still occur with COPD patients in the form of exacerbation or lead to the increased incidence of COPD in the general population. Further improvement in current air quality guidelines seems necessary at the government level, but other policy and exposure control measures could be implemented locally or at the personal level. Continued epidemiologic research, particularly long-term prospective cohort studies involving multiple countries or cities to evaluate the effects of multiple pollutants and their interactions on the COPD burden, is needed in both high-income and low-to middle-income countries. Additionally, more intervention studies targeting reduced exposures and improved outcomes specifically for COPD sufferers are needed.
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